Alkem Licenses Drug for Diabetic Neuropathy in India
October 10, 2024 15:24
Alkem Laboratories partners with Sonnet BioTherapeutics to develop and commercialize SON-080, a potential treatment for diabetic peripheral neuropathy in India. The drug has shown promising nerve...